Steroid creams suppress inflammation quickly, but long-term, uncontrolled use can lead to skin thinning, visible vessels and a gradual loss of effect. These risks are greater on thin-skinned areas such as the face, eyelids and folds. For this reason, many patients and doctors prefer to turn to cortisone-free options wherever possible.
The good news is that there are now many evidence-based, cortisone-free options. Calcineurin inhibitors are used safely on sensitive sites, while PDE-4 inhibitors target inflammation to ease itch and redness. Barrier repair with ceramide moisturisers both supports treatment and lowers the frequency of flares, forming the foundation of the maintenance period.
In more widespread or resistant disease, cortisone-free systemic options come into play. NB-UVB phototherapy at 311 nm is suitable even in pregnancy and children. When it is not enough, screening is followed by IL-17, IL-23 or IL-4/13 targeted biologics and monitored systemic drugs. This makes strong, sustainable control possible without depending on cortisone.
At Clinovia our default approach is cortisone-free; steroids are used only when truly needed, briefly and under control. In addition, we assess systemic factors such as vitamin D, zinc, iron, thyroid and gut barrier health, and work to reduce triggers. We measure response with PASI, EASI and DLQI and run the plan in five languages, tailored to each patient.